Kuan Arthur — SEC insider filings

SEC reporting owner CIK 2007101. 6 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-10-07 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CG Oncology, Inc. (CGON)Chief Executive Officer, Director61 leg · 30,000 sh · $2,366,425—9

Insider filings — Kuan Arthur

FiledFormIssuerReported transactionsSource
2026-11-184CG Oncology, Inc. (CGON)Purchase (P): 30,000.32 @ $78.88EDGAR
2026-04-164CG Oncology, Inc. (CGON)Grant/award (A): 271,600 (derivative) @ $0EDGAR
2026-03-134CG Oncology, Inc. (CGON)Option exercise (M): 64,612 @ $1.72 · Tax withholding (F): 1,847 @ $60.15 · Option exercise (M): 64,612 (derivative) @ $0EDGAR
2026-03-064CG Oncology, Inc. (CGON)Option exercise (M): 102,871 @ $1.72 · Tax withholding (F): 2,871 @ $61.61 · Option exercise (M): 102,871 (derivative) @ $0EDGAR
2025-04-164CG Oncology, Inc. (CGON)Grant/award (A): 527,660 (derivative) @ $0EDGAR
2024-10-074CG Oncology, Inc. (CGON)Grant/award (A): 397,800 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2007101 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs